Advisors who are monitoring hospitals’ drug supply tactics are skeptical that the hospitals are seeking out these options with the intentions to drive down costs. (Photo: Shutterstock)

Pharmaceutical drug pricing continues to be a high cost driver for many health plans in America, and hospitals are attempting to curb that cost by manufacturing their own generic drugs, as well as seeking out more affordable bulk order supply chains.

According to a recent ABC News report, Civica Rx plans to start manufacturing 14 widely used hospital drugs that have long been in short supply. The company is not disclosing the drug names for competitive reasons, but they include a mix of generic pills, patches and injectables for treating infections, pain and heart conditions.

Complete your profile to continue reading and get FREE access to, part of your ALM digital membership.

Your access to unlimited content isn’t changing.
Once you are an ALM digital member, you’ll receive:

  • Critical information including cutting edge post-reform success strategies, access to educational webcasts and videos, resources from industry leaders, and informative Newsletters.
  • Exclusive discounts on ALM, BenefitsPRO magazine and events.
  • Access to other award-winning ALM websites including and

Already have an account?



Join BenefitsPRO

Don’t miss crucial news and insights you need to navigate the shifting employee benefits industry. Join now!

  • Unlimited access to - your roadmap to thriving in a disrupted environment
  • Access to other award-winning ALM websites including and
  • Exclusive discounts on and ALM events.

Already have an account? Sign In Now
Join BenefitsPRO

Copyright © 2023 ALM Global, LLC. All Rights Reserved.